ScholarLens Back to search
2001•Journal of HepatologyRequires access

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation – possible role of mutations in the YMDD motif prior totransplantation as a risk factor for reinfection

Jens Rosenau, Mathias Bähr, Hans L. Tillmann, Christian Trautwein, Jürgen Klempnauer, Michael P. Manns, Klaus H.W. Böker

Open publisher page 197 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 197 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Lamivudine, Medicine, Hepatitis B immune globulin, Hepatitis B virus, Hepatitis B, Liver transplantation, Titer, Gastroenterology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation – possible role of mutations in the YMDD motif prior totransplantation as a risk factor for reinfection — Research Paper | ScholarLens